Piperazine,1,2,5-trimethyl-4-[(2E,4E)-1-oxo- 2,4-hexadienyl]-,(2R,5S)-rel-(+)- (24779-38-2)

Identification
Name:	Piperazine,1,2,5-trimethyl-4-[(2E,4E)-1-oxo- 2,4-hexadienyl]-,(2R,5S)-rel-(+)-
Synonyms:	Nigragilline
CAS:	24779-38-2
Molecular Formula:	C13H22N2O
Molecular Weight:	222.3266
InChI:	InChI=1/C13H22N2O/c1-5-6-7-8-13(16)15-10-11(2)14(4)9-12(15)3/h5-8,11-12H,9-10H2,1-4H3/b6-5+,8-7+/t11-,12+/m1/s1
Molecular Structure:
Properties
Flash Point:	354.7°Cat760mmHg
Boiling Point:	354.7°Cat760mmHg
Density:	0.953g/cm3
Refractive index:	1.491
Flash Point:	354.7°Cat760mmHg
Safety Data

Other Product

2-Oxazolidinone, 4-methyl-3-[(2E,4E)-1-oxo-2,4-hexadienyl]-5-phenyl-,(4R,5S)-
Benzenesulfonamide,N-(2E,4E)-2,4-hexadienyl-N-[(1R,2R)-2-hydroxycyclohexyl]-4-methyl-,rel-
Bicyclo[2.2.2]octane-2,6-dione,8-[(2R)-2,5- dihydro-3-hydroxy-2,4-dimethyl-5-oxo-2- furanyl]-3-hydroxy-5-[(2E,4E)-1-hydroxy-2,- 4-hexadienylidene]-1,3-dimethyl-7-[(2E,4E)- 1-oxo-2,4-hexadienyl]-,(1S,3R,4R,5Z,7S,8R)- rel-(+)-
3-Isoquinolinecarboxylic acid,1,2,3,4-tetrahydro-7-[2-[5-methyl-2-(4-methyl-1-pentenyl)-4-oxazolyl]ethoxy]-2-[(2E,4E)-1-oxo-2,4-hexadienyl]-, (3S)-
3-Isoquinolinecarboxylic acid,1,2,3,4-tetrahydro-7-[2-[5-methyl-2-(1-methyl-1-pentenyl)-4-oxazolyl]ethoxy]-2-[(2E,4E)-1-oxo-2,4-hexadienyl]-, (3S)-
3-Isoquinolinecarboxylic acid,7-[2-[2-(1E)-1-hexenyl-5-methyl-4-oxazolyl]ethoxy]-1,2,3,4-tetrahydro-2-[(2E,4E)-1-oxo-2,4-hexadienyl]-, methyl ester, (3S)-
3-Isoquinolinecarboxylic acid,7-[2-[2-(1E)-1-hexenyl-5-methyl-4-oxazolyl]ethoxy]-1,2,3,4-tetrahydro-2-[(2E,4E)-1-oxo-2,4-hexadienyl]-, (3S)-
3-Isoquinolinecarboxylic acid,7-[2-[2-[(1E)-3,3-dimethyl-1-butenyl]-5-methyl-4-oxazolyl]ethoxy]-1,2,3,4-tetrahydro-2-[(2E,4E)-1-oxo-2,4-hexadienyl]-, (3S)-
3-Isoquinolinecarboxylic acid,7-[2-[2-[(1E)-4,4-dimethyl-1-pentenyl]-5-methyl-4-oxazolyl]ethoxy]-1,2,3,4-tetrahydro-2-[(2E,4E)-1-oxo-2,4-hexadienyl]-, (3S)-
3-Isoquinolinecarboxylic acid,7-[2-(2-cyclohexyl-5-methyl-4-oxazolyl)ethoxy]-1,2,3,4-tetrahydro-2-[(2E,4E)-1-oxo-2,4-hexadienyl]-, (3S)-
3a,7-Epoxy-3aH-furo[3,2-b]oxocin-3-carboxylicacid,5-[(1R,2E,4E)-6-(2,5-dihydro-4-hydroxy-1-methyl-2-oxo-1H-pyrrol-3-yl)-1,3-dimethyl-6-oxo-2,4-hexadienyl]octahydro-2,6,9a-trimethyl-8-oxo-,methyl ester, (2R,3S,3aS,5R,6R,7S,9aS)- (9CI)
2-Propenoic acid, 3-[[(2E,4E)-1-oxo-2,4-hexadienyl]amino]-, 2-propenylester, (2E)-
3,4,5-Piperidinetriol,1-(2,4-hexadienyl)-2-(hydroxymethyl)-, [2R-[1(2E,4E),2a,3b,4a,5b]]- (9CI)
2-Penten-1-ol, 5-[(4R,5S)-2,2,5-trimethyl-1,3-dioxan-4-yl]-, acetate,(2E)-rel-
2,4-Cyclohexadien-1-one,3,6-bis(acetyloxy)-2,6-dimethyl-4-[(2E,4E)-1-oxo-2,4-hexadienyl]-
2,4-Cyclohexadien-1-one,3,6-dihydroxy-2,6-dimethyl-4-[(2E,4E)-1-oxo-2,4-hexadienyl]-
2,4-Cyclohexadien-1-one,3,6-dihydroxy-2,6-dimethyl-4-[(2E,4E)-1-oxo-2,4-hexadienyl]-, (6S)-
Bicyclo[2.2.2]oct-5-en-2-one,8-(2,4- dihydroxy-3,5-dimethylbenzoyl)-3,6- dihydroxy-1,3-dimethyl-5-[(2E,4E)-1-oxo-2,- 4-hexadienyl]-7-(1E)-1-propenyl-,(1R,3S,- 4S,7R,8R)-
1-[(2E,4E)-1-Oxo-2,4-hexadienyl]piperidine
2,4-Pentadienoic acid,5-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-,(2E,4E)-